Skip to main content
SpringerLink
Log in

A Review of Quality-of-Life Assessment Measures in Schizophrenia: Limitations and Future Developments

  • Chapter
  • First Online:
Beyond Assessment of Quality of Life in Schizophrenia

  • 991 Accesses

Abstract

The assessment of quality of life (QoL) in patients with schizophrenia is an area of growing concern since it is considered an essential distal outcome for clinical trials and patient management (Auquier et al. 2003; Awad and Voruganti 2012) according to the patient-reported outcome (PRO) movement in medicine (see Fig. 5.1). Its evaluation is founded on the notion that every patient has a right to self-determination in health-care decisions and his/her subjective perspective should be considered in both diagnosis and care planning processes (Awad and Voruganti 2012; Badia et al. 1999; Bilker et al. 2003).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Auquier P, Simeoni MC, Sapin C, Reine G, Aghababian V, Cramer J, et al. Development and validation of a patient-based health-related quality of life questionnaire in schizophrenia: the S-QoL. Schizophr Res. 2003;63(1–2):137–49.

    Article  CAS  PubMed  Google Scholar 

  • Awad AG, Voruganti LN. Measuring quality of life in patients with schizophrenia: an update. Pharmacoeconomics. 2012;30(3):183–95.

    Article  PubMed  Google Scholar 

  • Badia X, Roset M, Montserrat S, Herdman M, Segura A. The Spanish version of EuroQol: a description and its applications. European quality of life scale. Med Clin. 1999;112 Suppl 1:79–85.

    Google Scholar 

  • Bilker WB, Brensinger C, Kurtz MM, Kohler C, Gur RC, Siegel SJ, et al. Development of an abbreviated schizophrenia quality of life scale using a new method. Neuropsychopharmacology. 2003;28(4):773–7.

    Article  PubMed  Google Scholar 

  • Bobes J. Current status of quality of life assessment in schizophrenic patients. Eur Arch Psychiatry Clin Neurosci. 2001;251 Suppl 2:II38–42.

    Article  PubMed  Google Scholar 

  • Bobes J, Garcia-Portilla P, Saiz PA, Bascaran T, Bousono M. Quality of life measures in schizophrenia. Eur Psychiatry. 2005;20 Suppl 3:S313–7.

    Article  PubMed  Google Scholar 

  • Bobes J, Garcia-Portilla MP, Bascaran MT, Saiz PA, Bousono M. Quality of life in schizophrenic patients. Dialogues Clin Neurosci. 2007;9(2):215–26.

    PubMed  PubMed Central  Google Scholar 

  • Brooks R. EuroQol: the current state of play. Health Policy. 1996;37:53–72.

    Article  CAS  PubMed  Google Scholar 

  • Browne S, Roe M, Lane A, Gervin M, Morris M, Kinsella A, et al. Quality of life in schizophrenia: relationship to sociodemographic factors, symptomatology and tardive dyskinesia. Acta Psychiatr Scand. 1996;94(2):118–24.

    Article  CAS  PubMed  Google Scholar 

  • Bullinger M, Quitmann J. Quality of life as patient-reported outcomes: principles of assessment. Dialogues Clin Neurosci. 2014;16(2):137–45.

    PubMed  PubMed Central  Google Scholar 

  • Calman KC. Quality of life in cancer patients – an hypothesis. J Med Ethics. 1984;10(3):124–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cella D, Riley W, Stone A, Rothrock N, Reeve B, Yount S, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008. J Clin Epidemiol. 2010;63(11):1179–94.

    Article  PubMed  PubMed Central  Google Scholar 

  • Endicott J, Nee J, Harrison W, Blumenthal R. Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull. 1993;29(2):321–6.

    CAS  PubMed  Google Scholar 

  • Evenson RC, Vieweg BW. Using a quality of life measure to investigate outcome in outpatient treatment of severely impaired psychiatric clients. Compr Psychiatry. 1998;39(2):57–62.

    Article  CAS  PubMed  Google Scholar 

  • Fervaha G, Remington G. Validation of an abbreviated quality of life scale for schizophrenia. Eur Neuropsychopharmacol. 2013;23(9):1072–7.

    Article  CAS  PubMed  Google Scholar 

  • Fervaha G, Foussias G, Siddiqui I, Agid O, Remington G. Abbreviated quality of life scales for schizophrenia: comparison and utility of two brief community functioning measures. Schizophr Res. 2014;154(1–3):89–92.

    Article  PubMed  Google Scholar 

  • Gaite L, Vazquez-Barquero JL, Arrizabalaga Arrizabalaga A, Schene AH, Welcher B, Thornicroft G, et al. Quality of life in schizophrenia: development, reliability and internal consistency of the Lancashire Quality of Life Profile – European version. EPSILON study 8. European Psychiatric Services: Inputs Linked to Outcome Domains and Needs. Br J Psychiatry Suppl. 2000;39:s49–54.

    Article  PubMed  Google Scholar 

  • Garcia-Portilla MP, Garcia-Alvarez L, Menendez-Miranda I, Al-Halabi S, Bobes-Bascaran MT, Saiz-Martinez PA, et al. Escalas de funcionalidad, discapacidad y calidad de vida en esquizofrenia. Drugs in context. Barcelona: J&C Ediciones Medicas, SL; 2015.

    Google Scholar 

  • Gomez JC, Sacristan JA, Hernandez J, Breier A, Ruiz Carrasco P, Anton Saiz C, et al. The safety of olanzapine compared with other antipsychotic drugs: results of an observational prospective study in patients with schizophrenia (EFESO study). Pharmacoepidemiologic study of olanzapine in schizophrenia. J Clin Psychiatry. 2000;61(5):335–43.

    Article  CAS  PubMed  Google Scholar 

  • Harvey PD. Assessment of everyday functioning in schizophrenia: implications for treatments aimed at negative symptoms. Schizophr Res. 2013;150(2–3):353–5.

    Article  PubMed  Google Scholar 

  • Hayhurst KP, Massie JA, Dunn G, Lewis SW, Drake RJ. Validity of subjective versus objective quality of life assessment in people with schizophrenia. BMC Psychiatry. 2014;14:365.

    Article  PubMed  PubMed Central  Google Scholar 

  • Heinrichs DW, Hanlon TE, Carpenter Jr WT. The quality of life scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr Bull. 1984;10(3):388–98.

    Article  CAS  PubMed  Google Scholar 

  • Insel TR. Rethinking schizophrenia. Nature. 2010;468:187–93.

    Article  CAS  PubMed  Google Scholar 

  • Karow A, Wittmann L, Schottle D, Schafer I, Lambert M. The assessment of quality of life in clinical practice in patients with schizophrenia. Dialogues Clin Neurosci. 2014;16(2):185–95.

    PubMed  PubMed Central  Google Scholar 

  • Kind P. The EuroQoL instrument: an index of HRQOL. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. 2nd ed. Philadelphia: Lippincott-Raven; 1996. p. 191–201.

    Google Scholar 

  • Lehman AF. The effects of psychiatric symptoms on quality of life assessments among the chronic mentally ill. Eval Program Plann. 1983;6(2):143–51.

    Article  CAS  PubMed  Google Scholar 

  • Lehman AF. A quality of life interview for the chronically mentally ill. Eval Program Plann. 1988;11:51–62.

    Article  Google Scholar 

  • Lehman AF, Postrado LT, Rachuba LT. Convergent validation of quality of life assessments for persons with severe mental illnesses. Qual Life Res. 1993;2(5):327–33.

    Article  CAS  PubMed  Google Scholar 

  • Lieberman JA, Perkins D, Belger A, Chakos M, Jarskog F, Boteva K, Gilmore J. The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches. Biol Psychiatry. 2001;50:884–97.

    Article  CAS  PubMed  Google Scholar 

  • Naber D. A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables. Int Clin Psychopharmacol. 1995;10 Suppl 3:133–8.

    PubMed  Google Scholar 

  • Naber D, Moritz S, Lambert M, Pajonk FG, Holzbach R, Mass R, et al. Improvement of schizophrenic patients’ subjective well-being under atypical antipsychotic drugs. Schizophr Res. 2001;50(1–2):79–88.

    Article  CAS  PubMed  Google Scholar 

  • Oliver JP, Huxley PJ, Priebe S, Kaiser W. Measuring the quality of life of severely mentally ill people using the Lancashire quality of life profile. Soc Psychiatry Psychiatr Epidemiol. 1997;32(2):76–83.

    Article  CAS  PubMed  Google Scholar 

  • Orsel S, Akdemir A, Dag I. The sensitivity of quality-of-life scale WHOQOL-100 to psychopathological measures in schizophrenia. Compr Psychiatry. 2004;45(1):57–61.

    Article  PubMed  Google Scholar 

  • Park IJ, Jung DC, Hwang SS, Jung HY, Yoon JS, Kim CE, et al. Refinement of the SWN-20 based on the Rasch rating model. Compr Psychiatry. 2015;60:134–41.

    Article  PubMed  Google Scholar 

  • Priebe S, Huxley P, Knight S, Evans S. Application and results of the Manchester Short Assessment of Quality of Life (MANSA). Int J Soc Psychiatry. 1999;45(1):7–12.

    Article  CAS  PubMed  Google Scholar 

  • Prieto L, Sacristan JA, Hormaechea JA, Casado A, Badia X, Gomez JC. Psychometric validation of a generic health-related quality of life measure (EQ-5D) in a sample of schizophrenic patients. Curr Med Res Opin. 2004;20(6):827–35.

    Article  CAS  PubMed  Google Scholar 

  • Pukrop R, Schlaak V, Moller-Leimkuhler AM, Albus M, Czernik A, Klosterkotter J, et al. Reliability and validity of quality of life assessed by the short-form 36 and the modular system for quality of life in patients with schizophrenia and patients with depression. Psychiatry Res. 2003;119(1–2):63–79.

    Article  PubMed  Google Scholar 

  • Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001;33(5):337–43.

    Article  CAS  PubMed  Google Scholar 

  • Revicki DA, Kleinman L, Cella D. A history of health-related quality of life outcomes in psychiatry. Dialogues Clin Neurosci. 2014;16(2):127–35.

    PubMed  PubMed Central  Google Scholar 

  • Ritsner M, Kurs R, Gibel A, Ratner Y, Endicott J. Validity of an abbreviated quality of life enjoyment and satisfaction questionnaire (Q-LES-Q-18) for schizophrenia, schizoaffective, and mood disorder patients. Qual Life Res. 2005;14(7):1693–703.

    Article  PubMed  Google Scholar 

  • Schmidt P, Clouth J, Haggenmuller L, Naber D, Reitberger U. Constructing an Index for the Subjective Well-being Under Neuroleptics scale (SWN), short form: applying structural equation modeling for testing reliability and validity of the index. Qual Life Res. 2006;15(7):1191–202.

    Article  PubMed  Google Scholar 

  • Skantze K, Malm U, Dencker SJ, May PR, Corrigan P. Comparison of quality of life with standard of living in schizophrenic out-patients. Br J Psychiatry. 1992;161:797–801.

    Article  CAS  PubMed  Google Scholar 

  • Voruganti LN, Awad AG. Personal evaluation of transitions in treatment (PETiT): a scale to measure subjective aspects of antipsychotic drug therapy in schizophrenia. Schizophr Res. 2002;56(1–2):37–46.

    Article  PubMed  Google Scholar 

  • Vothknecht S, Meijer C, Zwinderman A, Kikkert M, Dekker J, van Beveren N, et al. Psychometric evaluation of the Subjective Well-being Under Neuroleptic Treatment Scale (SWN) in patients with schizophrenia, their relatives and controls. Psychiatry Res. 2013;206(1):62–7.

    Article  PubMed  Google Scholar 

  • Ware Jr JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–83.

    Article  PubMed  Google Scholar 

  • Ware Jr J, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220–33.

    Article  PubMed  Google Scholar 

  • Ware JE, Kosinski M, Turner-Bowker DM. User’s manual for the SF-12v2 health survey with a supplement documenting SF-12 health survey. Lincoln: Quality Metric Incorporated; 2002.

    Google Scholar 

  • WHO. Measuring quality of life. The development of the World Health Organization Quality of Life Instrument (WHOQOL-100). Genève: WHO; 1993.

    Google Scholar 

  • WHO. Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychol Med. 1998;28:551–8.

    Article  Google Scholar 

  • Wilkinson G, Hesdon B, Wild D, Cookson R, Farina C, Sharma V, et al. Self-report quality of life measure for people with schizophrenia: the SQLS. Br J Psychiatry. 2000;177:42–6.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Valencia, Spain

    María Teresa Bobes-Bascarán PhD

  2. Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Oviedo, Spain

    María Paz García-Portilla MD, PhD, Pilar A. Sáiz Martínez MD, PhD, Leticia García-Alvarez PhD, Susana Al-Halabí PhD, María Teresa Bascarán MD, PhD & Julio Bobes MD, PhD

  3. Department of Psychiatry, University of Oviedo, Oviedo, Spain

    María Paz García-Portilla MD, PhD, Pilar A. Sáiz Martínez MD, PhD, Leticia García-Alvarez PhD & Julio Bobes MD, PhD

  4. Mental Health Services of Asturias, Oviedo, Spain

    Isabel Menéndez-Miranda MD PhD

Authors
  1. María Teresa Bobes-Bascarán PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. María Paz García-Portilla MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pilar A. Sáiz Martínez MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Leticia García-Alvarez PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Isabel Menéndez-Miranda MD PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Susana Al-Halabí PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. María Teresa Bascarán MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Julio Bobes MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Julio Bobes MD, PhD .

Editor information

Editors and Affiliations

  1. Psychiatry, University of Toronto, Toronto, Ontario, Canada

    A. George Awad

  2. Department of Psychiatry, University of Western Ontario, London, Ontario, Canada

    Lakshmi N.P. Voruganti

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Bobes-Bascarán, M.T. et al. (2016). A Review of Quality-of-Life Assessment Measures in Schizophrenia: Limitations and Future Developments. In: Awad, A., Voruganti, L. (eds) Beyond Assessment of Quality of Life in Schizophrenia. Adis, Cham. https://doi.org/10.1007/978-3-319-30061-0_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-30061-0_5

  • Published:

  • Publisher Name: Adis, Cham

  • Print ISBN: 978-3-319-30059-7

  • Online ISBN: 978-3-319-30061-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation